stockportfolio.pro
LeMaitre Vascular, Inc. P/E Ratio 2009–2025
LeMaitre Vascular, Inc. (LMAT) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -1.6%/yr over 16 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 32.03 | -32.0% |
| FY 2024 | 47.08 | +13.6% |
| FY 2023 | 41.44 | -13.5% |
| FY 2022 | 47.92 | +24.5% |
| FY 2021 | 38.50 | +4.1% |
| FY 2020 | 36.99 | -3.5% |
| FY 2019 | 38.31 | +97.4% |
| FY 2018 | 19.40 | -43.0% |
| FY 2017 | 34.06 | -19.1% |
| FY 2016 | 42.07 | +13.4% |
| FY 2015 | 37.11 | +25.3% |
| FY 2014 | 29.61 | -15.4% |
| FY 2013 | 35.01 | +13.6% |
| FY 2012 | 30.82 | -19.9% |
| FY 2011 | 38.46 | +152.0% |
| FY 2010 | 15.26 | -63.4% |
| FY 2009 | 41.71 | — |
Source: LeMaitre Vascular, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for LeMaitre Vascular, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeLeMaitre Vascular, Inc. — frequently asked questions
What is LeMaitre Vascular, Inc.'s price-to-earnings ratio?
LeMaitre Vascular, Inc. (LMAT) reported price-to-earnings ratio of 32.03 for fiscal year 2025, per its SEC filings.
How has LeMaitre Vascular, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2009 and 2025, LMAT's price-to-earnings ratio declined at roughly 1.6% per year (compound annual rate), from 41.71 to 32.03.
Where does this data come from?
Figures are computed from LeMaitre Vascular, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.